intensiKey 1.1 adds new features, updated sets, and more video format support Las Vegas (PRWEB) February 25, 2012 intensiKey™ 1.1 adds new features

Chroma Therapeutics has reported positive data from a Phase I study with its oral, once-daily experimental cancer therapy CHR-2797 in the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes and multiple myelomas who have failed on, or who are unsuitable for, chemotherapy.